Form 4: Emergent BioSolutions SVP Jessica Perl Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
Jessica Perl, SVP, General Counsel, and Corporate Secretary of Emergent BioSolutions, reports disposing of 918 shares of common stock to cover tax obligations related to vesting restricted stock units.
Summary
- On February 9, 2025, Jessica Perl, SVP, General Counsel, and Corporate Secretary of Emergent BioSolutions Inc., disposed of 918 shares of common stock.
- The transaction was executed to cover tax obligations associated with the vesting and settlement of restricted stock units.
- The price per share was $10.
- Following the transaction, Perl directly owns 5,887 shares of Emergent BioSolutions Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 02/09/2025 | Date of transaction: Jessica Perl disposed of shares. |
| 02/11/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.